Tang B, Zhang Y, Zhou J, Xu Y, Li T R, Ding C Y
Radiology Department, Jiangsu Shuyang Traditional Chinese Medicine Hospital, Suqian 223600, China.
Nuclear Medicine Department, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Zhonghua Zhong Liu Za Zhi. 2017 Apr 23;39(4):280-285. doi: 10.3760/cma.j.issn.0253-3766.2017.04.008.
To investigate the relationship between metabolic parameters of primary lesion and clinicopathological features of patients with breast cancer. Clinical data of 78 patients with breast cancer undergone (18)F-FDG PET/CT before surgery was retrospectively analyzed. SUVmax, SUVmean and metabolic tumor volume (MTV) of primary lesions were measured by horizontal, sagittal and coronal position volume section with a threshold of 40% SUVmax. TLG was calculated and the highest SUVmax among metastatic lymph nodes was measured. SUVmax, SUVmean, MTV, TLG and the maximum diameter of 78 primary lesions were 6.64(1.85, 22.79), 3.88(1.30, 11.42), 13.36(1.66, 129.08)cm(3,) 47.92(2.85, 443.28)g and 2.35(1.23, 9.80)cm, respectively. SUVmax of metastatic lymph node was 5.12(2.38, 14.32). There were statistically significant differences of primary lesion metabolic parameters (SUVmax, MTV, TLG) in different pathological stages, T stages, with or without lymph node invasion (all <0.05). Only TLG of ER negative patients was higher than that of ER positive patients (<0.05). TLG, MTV of PR negative patients were higher than that of PR positive patients (both <0.05). No significant differences of metabolic parameters were found between HER-2 negative and positive patients (all >0.05). SUVmax, MTV, TLG of primary lesion were positively associated with Ki-67 and the maximum diameter (all <0.05), and the correlation coefficient of TLG was the highest. SUVmax, SUVmean, MTV and TLG were all positively associated with T stage (all <0.05), and the correlation coefficient of TLG was the highest. None of the parameters had correlation with N stage(all >0.05). Only TLG had positive correlation with clinical stage (<0.05). SUVmax of metastatic lymph node was positively associated with metabolic parameters of primary lesion, T stage and clinical stage, respectively (all <0.05). (18)F-FDG PET/CT metabolic parameters, especially TLG has the highest correlation with clinicopathological features of breast cancer. SUVmax of metastatic lymph node was positively associated with metabolic parameters of primary lesion and clinical stage.
探讨乳腺癌原发灶代谢参数与患者临床病理特征之间的关系。回顾性分析78例乳腺癌患者术前进行(18)F-FDG PET/CT检查的临床资料。通过水平、矢状和冠状位容积切片测量原发灶的SUVmax、SUVmean和代谢肿瘤体积(MTV),阈值为SUVmax的40%。计算TLG并测量转移淋巴结中的最高SUVmax。78个原发灶的SUVmax、SUVmean、MTV、TLG和最大直径分别为6.64(1.85,22.79)、3.88(1.30,11.42)、13.36(1.66,129.08)cm³、47.92(2.85,443.28)g和2.35(1.23,9.80)cm。转移淋巴结的SUVmax为5.12(2.38,14.32)。原发灶代谢参数(SUVmax、MTV、TLG)在不同病理分期、T分期、有无淋巴结侵犯方面差异均有统计学意义(均<0.05)。仅ER阴性患者的TLG高于ER阳性患者(<0.05)。PR阴性患者的TLG、MTV高于PR阳性患者(均<0.05)。HER-2阴性和阳性患者之间代谢参数差异均无统计学意义(均>0.05)。原发灶的SUVmax、MTV、TLG与Ki-67及最大直径均呈正相关(均<0.05),且TLG的相关系数最高。SUVmax、SUVmean、MTV和TLG均与T分期呈正相关(均<0.05),且TLG的相关系数最高。各参数与N分期均无相关性(均>0.05)。仅TLG与临床分期呈正相关(<0.05)。转移淋巴结的SUVmax分别与原发灶代谢参数、T分期和临床分期呈正相关(均<0.05)。(18)F-FDG PET/CT代谢参数,尤其是TLG与乳腺癌临床病理特征的相关性最高。转移淋巴结的SUVmax与原发灶代谢参数及临床分期呈正相关。